Join AARP
Get exclusive member benefits & effect social change. Join Today
WATCH THE NASCAR RACE ON SUNDAY – AND
CLICK HERE TO HELP END HUNGER IN AMERICA
Inside E Street
If you look in your medicine cabinet, chances are you'll see at least one of the following blockbuster drugs: Lipitor, Plavix, Lexapro or Singulair. They lower cholesterol, help prevent heart attacks and treat depression, asthma and allergies.
See also: Paying less for drugs in the Part D 'Doughnut Hole'.

What happens when prescription drugs are no longer under patent? — Photo by Tetra Images/GettyImages
They're also among the top selling prescription medicines going off the "patent cliff" — that's what the drug industry calls the moment patented drugs lose their exclusivity. This usually happens 15 years after the drug is introduced to the public — a time when pharmaceutical companies worry about making profits as generic competition enters the drug market.
This Inside E Street takes a look at the strategies pharmaceutical companies take once a blockbuster drug goes off patent — strategies aimed at limiting both competition and, unfortunately, your savings on your meds.
You may also like: Don't miss out on drug savings.
Prescription drugs are behind 1 in 4 cases of sexual problems. Are you taking any? read
Member access to caregiving support services with AARP® Caregiving Help and Advice from Genworth.
Members save 20% off on personal training and group fitness with American Council on Exercise.
Members save on hearing care with the AARP® Hearing Care Program provided by HearUSA.
Members receive exclusive member benefits and affect social change. Join Today
Find titles on brain health, drug alternatives and losing weight. Do
How to strengthen Social Security for future generations. Discuss
Share health coverage information and experiences common to being age 50+. Join
Share heart-smart recipes, fitness tips and stress relievers. Join
Tell Us WhatYou Think
Please leave your comment below.
You must be signed in to comment.
Sign In | RegisterMore comments »